Please find here below the program for the two days mini symposium onJune 4th (room C8:321) and June 5th (room A7:115). The mini symposium will be followed by an evaluation for the entire 3MK013 course where you are given an opportunity to help us improve this course.

Day 1, June 4
Time	Group	Students	Topic	Group leading the discussion
09.15 – 09.30	Introduction / set up
09.30 – 10.00	Group 1	Martha Crowe, Fatima Mohamud, Angelina Novak	Resistance development in Klebsiella pneumoniae upon combination therapy	Group 2
10.00 – 10.30	Group 3	Haunaz Jalal, Emelie Rigi, Fanny Schönfelder	Antibiotic-induced Prophage Mobilization in Bacteroides fragilis Isolates	Group 4
10.30 – 11.00	Coffee break
11.00 – 11.30	Group 2	Teresa Clemente Galdiano, Jaime Granado Leon, Carl Damell	Developing a NDM-beta-lactamase inhibitor based on zinc-ion chelation	Group 1
11.30 – 12.00	Group 4	Zala Bozanic, Yang Gao, Monika Vilemová	Chitosan Exposure of UPEC Intracellular Reservoirs to Prevent UTI Recurrence	Group 3
12.00 – 13.15	Lunch
13.15 – 13.45	Group 5	Elvira Larsson, Epameinondas Drakakis, Meda Skinkyte	HMO analogues as a prevention and treatment against CAUTIs	Group 6
13.45 – 14.15	Group 7	Lebin Yousif, Olga Borowska, Barbara Nowak	Delivery of Antibiotics to Acinetobacter baumannii using Phage Proteins	Group 8
14.15 – 14.45	Coffee break
14.45 – 15.15	Group 6	Ellen Sköldberg, Mariana Aleixo, Nina Flauger	The importance of iron transport mutations in cefiderocol resistance in Pseudomonas aeruginosa	Group 5
15.15 – 15.45	Group 8	Alice Andersson, Hanna Friberg, Moa Isaksson	Combining silver nanoparticles and antibiotics to combat MRSA	Group 7
15.45 – 16.15	Round up	All

Day 2, June 5
09.15 – 09.30	Introduction / set up
09.30 – 10.00	Group 9	Afroza Aftab Leena, Nelum Dilushi Pasikku Hannadige, Amlan Bhattacharjee	Dual-Vector Sepsis Therapy: CRISPR Phages and Adenoviral Immunomodulators.	Group 10
10.00 – 10.30	Group 11	Adam Sundell, Lorea Pagalday, Lara Norri	The synergistic combination of quorum-sensing inhibitors and antibiotic treatment against MRSA	Group 12
10.30 - 11.00	Coffee break
11.00 - 11.30	Group 10	Maryam Awale, Polina Vaulina, Siri Gustavsson	Monitoring presence of multidrug resistance in A. baumannii in ICU patients	Group 9
11.30 - 12.00	Group 12	Karaiskou Eleni, Evangelopoulos Vasileios Rafail	CRISPR/Cas9 for the reversion of antibiotic resistance in ESBL E. coli bacteria	Group 11
12.00 - 13.15	Lunch
13.15 - 13.45	Round up	All
13.45 - 14.15	Evaluation	All	Evaluation of entire course – 3MK013